BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Cash & Equivalents (2021 - 2026)

BullFrog AI Holdings' (BFRG) quarterly Cash & Equivalents came in at $6.9 million in Q2 2026, up 168.29% on a YoY basis from $2.6 million in Q2 2025, and up 216.81% quarter-over-quarter from $2.2 million in Q4 2025.

Analysis

BullFrog AI Holdings (BFRG) Cash & Equivalents (2021 - 2026) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Cash & Equivalents for 6 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Equivalents rose 168.29% year-over-year to $6.9 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (up 168.29% YoY), and the FY2025 full-year result was $2.2 million, down 59.83% from the prior year.
  • Cash & Equivalents advanced to $6.9 million in Q2 2026 per BFRG's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $7.0 million in Q1 2024 and bottomed at $57670.0 in Q4 2022.
  • Historically, Cash & Equivalents has averaged $4.1 million across 5 years, with a median of $4.0 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Cash & Equivalents soared 4451.29% in 2023, then sank 59.83% in 2025.
  • Over 5 years, Cash & Equivalents stood at $57670.0 in 2022, then jumped by 4451.29% to $2.6 million in 2023, then soared by 107.11% to $5.4 million in 2024, then plunged by 59.83% to $2.2 million in 2025, then surged by 216.81% to $6.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $6.9 million, $2.2 million, and $2.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 6.14 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 2.46 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 3.58 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 1.72 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.71 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 1.29 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 544.80 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 6.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.92 Mn
Dec 31, 2025 2.18 Mn
Sep 30, 2025 2.10 Mn
Jun 30, 2025 2.58 Mn
Mar 31, 2025 3.80 Mn
Dec 31, 2024 5.44 Mn
Sep 30, 2024 4.24 Mn
Jun 30, 2024 5.61 Mn
Mar 31, 2024 7.01 Mn
Dec 31, 2023 2.62 Mn
Sep 30, 2023 3.86 Mn
Jun 30, 2023 5.46 Mn
Mar 31, 2023 5.42 Mn
Dec 31, 2022 57,670.00
Dec 31, 2021 10,014.00